Please login to the form below

Not currently logged in
Email:
Password:

Biogen promotes Dr Paul McKenzie

He becomes pharmaceutical operations and technology EVP

Cambridge, Massachusetts-based Biogen has appointed Dr Paul McKenzie as executive vice president of pharmaceutical operations and technology.

Dr McKenzie will take up the new role and a place on the firm's management team from 1 July, reporting to chief executive officer Dr George Scangos.

The position will not only include responsibility for asset management, technical development, global manufacturing, supply chain operations and engineering, but also overseeing the construction and operation of a new biologic manufacturing facility in Solothurn, Switzerland.

Dr McKenzie joined Biogen earlier this year as senior vice president of global biologics, manufacturing and technical operations from Johnson & Johnson, where he held a number of leadership roles including vice president of research and development for J&J's Ethicon business.

Prior to that, Dr McKenzie worked at Janssen and also brings operations and R&D experience from Bristol-Myers Squibb and Merck.

Dr Scangos said: “With his extensive technical and development expertise, we believe Paul is ideally suited to lead the next phase of growth across Biogen's development and manufacturing operations.

“He will play an essential role, building upon our tradition of world-class manufacturing while leading the development of next generation capabilities to ensure global availability or our current and future therapies.”

1st July 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics